Integra Lifesciences Holdings (IART) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $25.8 million.
- Integra Lifesciences Holdings' Free Cash Flow rose 45958.66% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 11186.68%. This contributed to the annual value of $25.0 million for FY2024, which is 6584.48% down from last year.
- Integra Lifesciences Holdings' Free Cash Flow amounted to $25.8 million in Q3 2025, which was up 45958.66% from -$11.2 million recorded in Q2 2025.
- In the past 5 years, Integra Lifesciences Holdings' Free Cash Flow ranged from a high of $84.7 million in Q2 2021 and a low of -$40.2 million during Q1 2025
- Its 5-year average for Free Cash Flow is $29.4 million, with a median of $25.8 million in 2025.
- In the last 5 years, Integra Lifesciences Holdings' Free Cash Flow soared by 135299.19% in 2021 and then plummeted by 1390652.92% in 2025.
- Quarter analysis of 5 years shows Integra Lifesciences Holdings' Free Cash Flow stood at $41.8 million in 2021, then soared by 69.36% to $70.9 million in 2022, then tumbled by 51.73% to $34.2 million in 2023, then plummeted by 38.21% to $21.1 million in 2024, then rose by 21.81% to $25.8 million in 2025.
- Its last three reported values are $25.8 million in Q3 2025, -$11.2 million for Q2 2025, and -$40.2 million during Q1 2025.